GlassScriptPhysician profile
Canaan S Herrygers
NPI 1972828499
$1,308.67
in general payments reported to CMS, 2019-2025
19 companies · $304 in 2025
The $304 reported for 2025 was more than what 85% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $191 · 2020: $79.26 · 2021: $159 · 2022: $68.59 · 2023: $129 · 2024: $377 · 2025: $304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $811.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $810.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $375.90 | 2023-2025 | Azstarys |
| Pfizer INC. | $168.15 | 2019-2021 | |
| Cranial Technologies, INC | $130.80 | 2019-2024 | Doc Band |
| Kaleo, INC. | $82.84 | 2019-2023 | Auvi-Q |
| Merck Sharp & Dohme LLC | $80.30 | 2019-2025 | Gardasil 9, Vaxelis, Gardasil |
| Sanofi-Aventis U.S. LLC | $78.74 | 2023-2024 | |
| Sobi, INC | $66.44 | 2021-2022 | |
| Glaxosmithkline, LLC. | $65.20 | 2022-2024 | Bexsero |
| Supernus Pharmaceuticals, INC. | $38.95 | 2024 | Qelbree |
| Astrazeneca Pharmaceuticals LP | $30.17 | 2024 | Flumist Quadrivalent |
| Ars Pharmaceuticals Operations, INC. | $28.50 | 2025 | Neffy |
| Hologic Sales and Service, LLC | $25.82 | 2024 | Thinprep 2000 Processor, Aptima |
| Takeda Pharmaceuticals U.S.A., INC. | $24.51 | 2021 | |
| Verrica Pharmaceuticals INC. | $24.10 | 2025 | Ycanth |
| Phadia US INC. | $21.33 | 2024 | Immunocap |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $18.26 | 2020 | |
| Collegium Pharmaceutical, INC. | $17.94 | 2025 | Jornay Pm |
| Tris Pharma INC | $15.43 | 2020 | |
| Genentech USA, INC. | $15.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Canaan Herrygers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.